AAAAAA

   
Results: 1-8 |
Results: 8
The-141C Ins/Del polymorphism in the dopamine D-2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients
Authors: Suzuki, A Kondo, T Mahara, K Yasui-Furukori, N Ishida, M Furukori, H Kaneko, S Inoue, Y Otani, K
Citation: A. Suzuki et al., The-141C Ins/Del polymorphism in the dopamine D-2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients, PHARMACOGEN, 11(6), 2001, pp. 545-550
Association between TaqI A dopamine D-2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report
Authors: Suzuki, A Kondo, T Mihara, K Yasui-Furukori, N Otani, K Furukori, H Kaneko, S Inoue, Y
Citation: A. Suzuki et al., Association between TaqI A dopamine D-2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report, EUR ARCH PS, 251(2), 2001, pp. 57-59
Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol
Authors: Yasui-Furukori, N Kondo, T Suzuki, A Mihara, K Tokinaga, N Inoue, Y Otani, K Kaneko, S
Citation: N. Yasui-furukori et al., Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol, SCHIZOPHR R, 52(1-2), 2001, pp. 139-142
Effects of genetic polymorphism of CYP1A2 inducibility on the steady-stateplasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients
Authors: Mihara, K Kondo, T Suzuki, A Yasui-Furukori, N Ono, S Otani, K Kaneko, S
Citation: K. Mihara et al., Effects of genetic polymorphism of CYP1A2 inducibility on the steady-stateplasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients, PHARM TOX, 88(5), 2001, pp. 267-270
Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol
Authors: Mihara, K Suzuki, A Kondo, T Yasui-Furukori, N Ono, S Otani, K Kaneko, S Inoue, Y
Citation: K. Mihara et al., Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol, AM J MED G, 105(3), 2001, pp. 271-274
Different enantioselective 9-hydroxylation of risperidone by the two humanCYP2D6 and CYP3A4 enzymes
Authors: Yasui-Furukori, N Hidestrand, M Spina, E Facciola, G Scordo, MG Tybring, G
Citation: N. Yasui-furukori et al., Different enantioselective 9-hydroxylation of risperidone by the two humanCYP2D6 and CYP3A4 enzymes, DRUG META D, 29(10), 2001, pp. 1263-1268
No correlations between the urinary ratio of 6 beta-hydroxycortisol to free cortisol and pharmacokinetics of alprazolam
Authors: Yasui-Furukori, N Kondo, T Kubota, T Otake, H Ohkubo, T Nagasaki, T Sugawara, K Chiba, K Otani, K Kaneko, S
Citation: N. Yasui-furukori et al., No correlations between the urinary ratio of 6 beta-hydroxycortisol to free cortisol and pharmacokinetics of alprazolam, EUR J CL PH, 57(4), 2001, pp. 285-288
Association of the TaqI a polymorphism of the dopamine D-2 receptor gene with predisposition to neuroleptic malignant syndrome
Authors: Suzuki, A Kondo, T Otani, K Mihara, K Yasui-Furukori, N Sano, A Koshiro, K Kaneko, S
Citation: A. Suzuki et al., Association of the TaqI a polymorphism of the dopamine D-2 receptor gene with predisposition to neuroleptic malignant syndrome, AM J PSYCHI, 158(10), 2001, pp. 1714-1716
Risultati: 1-8 |